15th Annual Indy Hematology Review

Actions Panel

Registrations are closed

Thank you! We look forward to seeing you on March 10, 2018!

15th Annual Indy Hematology Review

By Indy Hematology Education, Inc.

Date and time

Saturday, March 10, 2018 · 7am - 6:30pm EST

Location

JW Marriott Indianapolis

10 S. West Street Indianapolis, IN 46204

Refund Policy

Contact the organizer to request a refund.

Description

Online Pre-Registration has closed. Please register onsite on Saturday, starting at 7:00 AM

15th Annual Indy Hematology Review

Presented by:

A full day of presentations by today's leaders in Hematology and Hematologic Malignancies.

ANNOUNCEMENT: Registration will close at 1:30 PM on Friday, March 9. It will re-open onsite at 7 AM on Saturday.

REFUND POLICY: Request a registration cancellation refund on or before March 1, 2018, to receive a Full Refund. After March 1, there is NO REFUND.

SCHOLARSHIPS: A limited number of scholarships are available for students, residents, and fellows on a first-come, first-served basis. To register for a scholarship, please contact erica@conventionmanagers.com for availability.

HOTEL RESERVATIONS: Make reservations online at https://aws.passkey.com/go/hemat or call the JW Marriott Indianapolis at 317-860-5800 or toll free at 1-888-236-2427. Mention “Indy Hematology Review” to receive the discounted rate of $186 plus tax (currently 17%). The block of discounted rooms will be released on Friday, February 16, 2018.

PARKING: Parking is available at the JW Marriott Indianapolis. 24-hour parking rates are currently: $43 on-site parking; $48 valet.

CONTINUING EDUCATION CREDITS:

LEARNING OBJECTIVES
At the completion of this activity, participants should be able to:

  • Discuss new emerging hematology therapies in general and for chronic Myeloid Leukemia, acute Promylelocytic and Myeloid Leukemia, and Myeloproliferative disorders.
  • Recognize molecular diagnosis, targeted therapies, and resistance mechanisms of Waldenstrom's Macroglobulinemia to assist in disease recognition.
  • Discuss the advancement of immune check point inhibitors within hematologic malignancies and updated treatment paradigms presented at the American Society of Hematology meeting in Atlanta, Georgia in December 2017.
  • Identify new regimens for Hematopoietic Stem Cell transplantation and identification of transplant candidates.
  • Review the advancement in benign hematology research.
  • Review new treatment regimens in chronic Lymphocytic Leukemia.

CME Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Indiana Association of Pathologists and Indy Hematology Education, Inc. The Indiana Association of Pathologists is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.

Designation Statement: The Indiana Association of Pathologists designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: In accordance with the ACCME Standards for Commercial Support, educational programs sponsored by the Indiana Association of Pathologists (IAP) must demonstrate balance, independence, objectivity, and scientific rigor. Prior to the activity, all faculty, authors, editors, and planning committee members participating in an IAP-sponsored activity are required to disclose to attendees any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Nurses Accreditation Statement: This continuing nursing education activity was approved by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Assigned ONA #21199. This program is approved for 7.75 contact hours.

Pharmacists Accreditation Statement: Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is a knowledge based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-18-001-L01-P. This program is approved for 7.75 contact hours (0.775 CEU's).

QUESTIONS? Please contact Erica Olivero, erica@conventionmanagers.com, 317-713-1530.

WEBSITE: http://www.indyhematologyreview.com/

Organized by

Sales Ended